Transurethral resection of prostate (TURP) remains the gold standard surgical therapy
for symptomatic benign prostatic enlargement, with reported International Prostate
Symptom Score reduction of up to 70%. However, as many as 20% of patients can have
significant complications including sexual dysfunction, perioperative bleeding requiring
blood transfusion, and incontinence. Intractable hematuria from the prostate can be
life-threatening, and its management remains a difficult clinical problem. Prostate
artery embolization (PAE) is occasionally indicated in such patients when all other
measures have failed. PAE has been used to treat benign prostatic hyperplasia; however,
literature related to its use for bleeding following TURP remains limited. We report
a case of an elderly male who presented with recurrent episodes of hematuria following
TURP and was successfully treated by endovascular management.
Benign prostatic hyperplasia - hematuria - prostatic artery embolization
